Loss of the APP regulator RHBDL4 preserves memory in an Alzheimer’s disease mouse model

Ylauna Christine Megane Penalva,Sandra Paschkowsky,Jingyun Yang,Sherilyn Junelle Recinto,Jessica Cinkorpumin,Marina Ruelas Hernandez,Bin Xiao,Albert Nitu,Helen Yee-Li Wu,Hans Markus Munter,Bernadeta Michalski,Margaret Fahnestock,William Pastor,David A. Bennett,Lisa Marie Munter

DOI: https://doi.org/10.1101/2024.02.22.579698

2024-09-08

Abstract:Characteristic cerebral pathological changes of Alzheimer’s disease (AD) such as glucose hypometabolism or the accumulation of cleavage products of the amyloid precursor protein (APP), known as Aβ peptides, lead to sustained endoplasmic reticulum (ER) stress and neurodegeneration. To preserve ER homeostasis, cells activate their unfolded protein response (UPR). The rhomboid-like-protease 4 (RHBDL4) is an enzyme that participates in the UPR by targeting proteins for proteasomal degradation. We demonstrated previously that RHBLD4 cleaves APP in HEK293T cells, leading to decreased total APP and Aβ. More recently, we showed that RHBDL4 processes APP in mouse primary mixed cortical cultures as well. Here, we aim to examine the physiological relevance of RHBDL4 in the brain. We first found that brain samples from AD patients and an AD mouse model (APPtg) showed increased RHBDL4 mRNA and protein expression. To determine the effects of RHBDL4’s absence on APP physiology , we crossed APPtg mice to a RHBDL4 knockout (R4 ) model. RHBDL4 deficiency in APPtg mice led to increased total cerebral APP and amyloidogenic processing when compared to APPtg controls. Contrary to expectations, as assessed by cognitive tests, RHBDL4 absence rescued cognition in 5-month-old female APPtg mice. Informed by unbiased RNAseq data, we demonstrated and that RHBDL4 absence leads to greater levels of active β-catenin due to decreased proteasomal clearance. Decreased β-catenin activity is known to underlie cognitive defects in APPtg mice and AD. Our work suggests that RHBDL4’s increased expression in AD, in addition to regulating APP levels, leads to aberrant degradation of β-catenin, contributing to cognitive impairment.

Animal Behavior and Cognition

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve This paper aims to explore the role of an enzyme called RHBDL4 in regulating amyloid precursor protein (APP) and its downstream signaling pathways in Alzheimer's disease (AD), and to study its impact on cognitive function. #### Main Research Content: 1. **Expression of RHBDL4 in AD**: - Researchers found that the mRNA and protein levels of RHBDL4 are significantly increased in AD patients and AD mouse models. - This increase may be related to endoplasmic reticulum (ER) stress, as a response mechanism to ER stress. 2. **Impact of RHBDL4 Deletion on APP Metabolism**: - Knocking out RHBDL4 in APP transgenic mice leads to an increase in total APP levels and amyloid-beta (Aβ) production, especially Aβ40. - These results further confirm the role of RHBDL4 in regulating APP levels. 3. **Impact of RHBDL4 Deletion on Cognitive Function**: - Despite the increase in APP levels and Aβ production due to RHBDL4 deletion, unexpectedly, this deletion restored cognitive function in 5-month-old female APP transgenic mice. - This suggests that RHBDL4 not only affects APP levels in the AD pathological process but may also influence cognitive function through other pathways. 4. **Changes in β-Catenin Expression and Activity**: - Deletion of RHBDL4 leads to an increase in β-catenin levels and activity, which may be due to impaired proteasomal degradation. - This increase in β-catenin levels may be one of the reasons for the restoration of cognitive function. #### Conclusion: Researchers propose that the upregulation of RHBDL4 in AD may not only be a response to ER stress but may also lead to the downregulation of the Wnt/β-catenin signaling pathway, thereby affecting cognitive function. Therefore, RHBDL4 is not only a regulator of APP metabolism but also a new negative regulator of the β-catenin signaling pathway, providing new insights for the treatment of AD.

Loss of the APP regulator RHBDL4 preserves memory in an Alzheimer’s disease mouse model

Deficiency of IKKβ in neurons ameliorates Alzheimer’s disease pathology in APP- and tau-transgenic mice

Distinct Rab7-related Endosomal–Autophagic–Lysosomal Dysregulation Observed in Cortex and Hippocampus in APPswe/PSEN1dE9 Mouse Model of Alzheimer's Disease

Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664.

BMP4 Overexpression Induces the Upregulation of APP/Tau and Memory Deficits in Alzheimer’s Disease

Decreased Hippocampal Cell Proliferation Correlates With Increased Expression Of Bmp4 In The Appswe/Ps1 Delta E9 Mouse Model Of Alzheimer'S Disease

ErbB4 Deficiency Exacerbates Olfactory Dysfunction in an Early-Stage Alzheimer’s Disease Mouse Model

Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites

Increased neuronal expression of the early endosomal adaptor APPL1 leads to endosomal and synaptic dysfunction with cholinergic neurodegeneration

Β-Amyloid Accumulation Enhances Microtubule Associated Protein Tau Pathology in an APPNL-G-F/MAPTP301S Mouse Model of Alzheimer’s Disease

Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease

Amyloid Precursor Protein-Mediated Endocytic Pathway Disruption Induces Axonal Dysfunction and Neurodegeneration.

β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity

Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer's Disease

An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments

Gene deletion of Pregnancy-associated Plasma Protein-A (PAPP-A) improves pathology and cognition in an Alzheimer's disease mouse model

P2‐359: Cathepsin B Gene Deletion or Inhibition Improves Memory Deficits in a Mouse Model of Alzheimer's Disease Expressing APP with the Wild‐type Beta‐secretase Site

Early Inhibition of Phosphodiesterase 4B (PDE4B) Instills Cognitive Resilience in APPswe/PS1dE9 Mice

Rpph1 Upregulates CDC42 Expression and Promotes Hippocampal Neuron Dendritic Spine Formation by Competing with Mir-330-5p.

Extracellular disposal of nuclear waste by APP: a protective mechanism impaired in Alzheimer’s disease

APOE4 Impairs Microglia ‐ Astrocyte Crosstalk in Alzheimer Disease